Imexpharm Corp (IMP) — Capital Reinvestment Ratio
Latest as of March 2026:
0.08x
Imexpharm Corp (IMP) has a Capital Reinvestment Ratio of 0.08x as of March 2026, meaning it reinvests 0% of its operating cash flow (₫103.49 Billion) in capital expenditures (₫7.79 Billion). See Imexpharm Corp (IMP) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.08x
Capex / Operating Cash Flow
Operating Cash Flow
₫103.49 Billion
VND
Capital Expenditures
₫7.79 Billion
VND
Data as of
Mar 2026
Most recent filing
Imexpharm Corp Capital Reinvestment Ratio (2019–2025)
This chart tracks Imexpharm Corp's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Imexpharm Corp (2019–2025)
Year-by-year Capital Reinvestment Ratio for Imexpharm Corp from 2019 to 2025. For live market cap and broader valuation context, see IMP company net worth.
| Year | Reinvestment Ratio | Operating CF (VND) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.50x | ₫54.17 Billion | ₫26.88 Billion | ▲ +10.9% |
| 2024 | 0.45x | ₫216.27 Billion | ₫96.77 Billion | ▲ +70.5% |
| 2022 | 0.26x | ₫378.60 Billion | ₫99.35 Billion | ▲ +16.6% |
| 2021 | 0.23x | ₫234.88 Billion | ₫52.86 Billion | ▼ -81.6% |
| 2020 | 1.23x | ₫73.15 Billion | ₫89.68 Billion | ▼ -37.7% |
| 2019 | 1.97x | ₫66.59 Billion | ₫131.12 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow